Atenolol nonclinical toxicology: Difference between revisions

Jump to navigation Jump to search
Gerald Chi (talk | contribs)
mNo edit summary
Alonso Alvarado (talk | contribs)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Atenolol#Nonclinical Toxicology]]
{{Atenolol}}
{{CMG}}; {{AE}} {{SS}}
 
==Nonclinical Toxicology==
 
Chronic studies employing oral atenolol performed in animals have revealed the occurrence of vacuolation of epithelial cells of Brunner's glands in the duodenum of both male and female dogs at all tested dose levels of atenolol (starting at 15 mg/kg/day or 7.5 times the maximum recommended human antihypertensive dose11, respectively).<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TENORMIN (ATENOLOL) TABLET [ASTRAZENECA PHARMACEUTICALS LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcfc9676-4edc-460e-6199-8161b824908f | publisher =  | date =  | accessdate = 5 February 2014 }}</ref>
 
==References==
 
{{Reflist|2}}


[[Category:Beta blockers]]
[[Category:Beta blockers]]
[[Category:Cardiovascular Drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
[[Category:Drugs]]

Latest revision as of 15:59, 21 July 2014